The mitochondria as a target for cardioprotection in acute myocardial ischemia

Pharmacology and Therapeutics

Volumn 142, Issue 1, 2014, Pages 33-40

  Ertracht, Offir ^a   Malka, Assaf ^b   Atar, Shaul ^a,c   Binah, Ofer ^b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

Biochemical pathways; Ischemia reperfusion; Mitochondria; Myocardial infarction

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ANION CHANNEL; APRIKALIM; ATORVASTATIN; BIMAKALIM; CROMAKALIM; CYCLOSPORIN A; DELCASERTIB; FAS ASSOCIATED DEATH DOMAIN PROTEIN; ISOFLURANE; MELATONIN; METFORMIN; MORPHINE; N OLEOYLETHANOLAMINE; NICORANDIL; NITRIC OXIDE; PINACIDIL; POTASSIUM CHANNEL; PROTEIN KINASE; RASAGILINE; RESVERATROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONFORMATIONAL TRANSITION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH ENERGY PHOSPHATE; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL VOLUME; MITOCHONDRION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

BIOCHEMICAL PATHWAYS; ISCHEMIA-REPERFUSION; MITOCHONDRIA; MYOCARDIAL INFARCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARDIOTONIC AGENTS; HUMANS; KATP CHANNELS; MITOCHONDRIA; MYOCARDIAL ISCHEMIA; NITRIC OXIDE;

EID: 84896734448     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.11.003     Document Type: Review

References (104)

1. F.G. Akar, M.A. Aon, G.F. Tomaselli, and B. O'Rourke The mitochondrial origin of postischemic arrhythmias J Clin Invest 115 2005 3527 3535
2. F.G. Akar, and B. O'Rourke Mitochondria are sources of metabolic sink and arrhythmias Pharmacol Ther 131 2011 287 294
3. G. Andreka, M. Vertesaljai, G. Szantho, G. Font, Z. Piroth, and G. Fontos et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs Heart 93 2007 749 752
4. A. Andrukhiv, A.D. Costa, I.C. West, and K.D. Garlid Opening mitoKATP increases superoxide generation from complex I of the electron transport chain Am J Physiol Heart Circ Physiol 291 2006 H2067 H2074
5. M.A. Aon, S. Cortassa, F.G. Akar, D.A. Brown, L. Zhou, and B. O'Rourke From mitochondrial dynamics to arrhythmias Int J Biochem Cell Biol 41 2009 1940 1948
6. M.A. Aon, S. Cortassa, E. Marban, and B. O'Rourke Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes J Biol Chem 278 2003 44735 44744
7. M.A. Aon, S. Cortassa, and B. O'Rourke Percolation and criticality in a mitochondrial network Proc Natl Acad Sci U S A 101 2004 4447 4452
8. M.A. Aon, S. Cortassa, and B. O'Rourke The fundamental organization of cardiac mitochondria as a network of coupled oscillators Biophys J 91 2006 4317 4327
9. L. Argaud, O. Gateau-Roesch, O. Raisky, J. Loufouat, D. Robert, and M. Ovize Postconditioning inhibits mitochondrial permeability transition Circulation 111 2005 194 197
10. G. Barreto-Torres, R. Parodi-Rullan, and S. Javadov The role of PPARalpha in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats Int J Mol Sci 13 2012 7694 7709
11. E. Bates, C. Bode, M. Costa, C.M. Gibson, C. Granger, and C. Green et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Circulation 117 2008 886 896
12. G.F. Baxter, M.M. Mocanu, B.K. Brar, D.S. Latchman, and D.M. Yellon Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK J Cardiovasc Pharmacol 38 2001 930 939
13. A.D. Beavis Properties of the inner membrane anion channel in intact mitochondria J Bioenerg Biomembr 24 1992 77 90
14. A.D. Beavis, and K.D. Garlid Inhibition of the mitochondrial inner membrane anion channel by dicyclohexylcarbodiimide. Evidence for a specific transport pathway J Biol Chem 263 1988 7574 7580
15. R.M. Bell, and D.M. Yellon Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 41 2003 508 515
16. R.M. Bell, and D.M. Yellon Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS J Mol Cell Cardiol 35 2003 185 193
17. A.S. Binbrek, N.S. Rao, N. Al Khaja, J. Assaqqaf, and B.E. Sobel Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction Am J Cardiol 104 2009 1035 1040
18. S. Boateng, and T. Sanborn Acute myocardial infarction Dis Mon 59 2013 83 96
19. K. Boengler, G. Heusch, and R. Schulz Mitochondria in postconditioning Antioxid Redox Signal 14 2011 863 880
20. H.E. Botker, R. Kharbanda, M.R. Schmidt, M. Bottcher, A.K. Kaltoft, and C.J. Terkelsen et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
21. B.K. Brar, A.K. Jonassen, A. Stephanou, G. Santilli, J. Railson, and R.A. Knight et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway J Biol Chem 275 2000 8508 8514
22. B.K. Brar, A. Stephanou, R. Knight, and D.S. Latchman Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death J Mol Cell Cardiol 34 2002 483 492
23. B.K. Brar, A. Stephanou, Z. Liao, R.M. O'Leary, D. Pennica, and D.M. Yellon et al. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation Cardiovasc Res 51 2001 265 274
24. D.A. Brown, M.A. Aon, F.G. Akar, T. Liu, N. Sorarrain, and B. O'Rourke Effects of 4′-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart Cardiovasc Res 79 2008 141 149
25. A.J. Bullard, P. Govewalla, and D.M. Yellon Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo Basic Res Cardiol 100 2005 397 403
26. V. Calderone, L. Testai, A. Martelli, S. Rapposelli, M. Digiacomo, and A. Balsamo et al. Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel Biochem Pharmacol 79 2010 39 47
27. A. Cave, and P. Garlick Re: preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium J Mol Cell Cardiol 32 2000 1759 1760
28. A.Y. Chan, C.L. Soltys, M.E. Young, C.G. Proud, and J.R. Dyck Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte J Biol Chem 279 2004 32771 32779
29. L. Chen, H. Hahn, G. Wu, C.H. Chen, T. Liron, and D. Schechtman et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC Proc Natl Acad Sci U S A 98 2001 11114 11119
30. P.C. Chiari, M.W. Bienengraeber, P.S. Pagel, J.G. Krolikowski, J.R. Kersten, and D.C. Warltier Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits Anesthesiology 102 2005 102 109
31. E.T. Chouchani, C. Methner, S.M. Nadtochiy, A. Logan, V.R. Pell, and S. Ding et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I Nat Med 19 2013 753 759
32. P. Cohen, and S. Frame The renaissance of GSK3 Nat Rev Mol Cell Biol 2 2001 769 776
33. + channels protect the myocardium against ischemia/reperfusion damage Circ Res 69 1991 571 581
34. A.D. Costa, and K.D. Garlid MitoKATP activity in healthy and ischemic hearts J Bioenerg Biomembr 41 2009 123 126
35. M. Das, J.E. Parker, and A.P. Halestrap Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria J Physiol 47 2003 893 902
36. S.M. Davidson, D. Hausenloy, M.R. Duchen, and D.M. Yellon Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection Int J Biochem Cell Biol 38 2006 414 419
37. + channel protects the ischemic heart Am J Physiol Heart Circ Physiol 283 2002 H284 H295
38. J.M. Downey, A.M. Davis, and M.V. Cohen Signaling pathways in ischemic preconditioning Heart Fail Rev 12 2007 181 188
39. O. Ertracht, E. Liani, N. Bachner-Hinenzon, O. Bar-Am, L. Frolov, and E. Ovcharenko et al. The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion Br J Pharmacol 163 2011 755 769
40. R.A. Forbes, C. Steenbergen, and E. Murphy Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism Circ Res 88 2001 802 809
41. M. Foretz, S. Hebrard, J. Leclerc, E. Zarrinpashneh, M. Soty, and G. Mithieux et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state J Clin Invest 120 2010 2355 2369
42. D.B. Foster, A.S. Ho, J. Rucker, A.O. Garlid, L. Chen, and A. Sidor et al. Mitochondrial ROMK channel is a molecular component of mitoK(ATP) Circ Res 111 2012 446 454
43. C. Garcia-Echeverria, and W.R. Sellers Drug discovery approaches targeting the PI3K/Akt pathway in cancer Oncogene 27 2008 5511 5526
44. + channels. Possible mechanism of cardioprotection Circ Res 81 1997 1072 1082
45. L. Gomez, H. Thibault, A. Gharib, J.M. Dumont, G. Vuagniaux, and P. Scalfaro et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice Am J Physiol Heart Circ Physiol 293 2007 H1654 H1661
46. O. Goransson, A. McBride, S.A. Hawley, F.A. Ross, N. Shpiro, and M. Foretz et al. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase J Biol Chem 282 2007 32549 32560
47. E.R. Gross, A.K. Hsu, and G.J. Gross Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts Circ Res 94 2004 960 966
48. E.R. Gross, A.K. Hsu, and G.J. Gross The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta Am J Physiol Heart Circ Physiol 291 2006 H827 H834
49. G.J. Grover Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia J Cardiovasc Pharmacol 24 Suppl. 4 1994 S18 S27
50. G.J. Grover, and K.D. Garlid ATP-sensitive potassium channels: a review of their cardioprotective pharmacology J Mol Cell Cardiol 32 2000 677 695
51. G.J. Grover, J.R. McCullough, D.E. Henry, M.L. Conder, and P.G. Sleph Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide J Pharmacol Exp Ther 251 1989 98 104
52. S. Gundewar, J.W. Calvert, S. Jha, I. Toedt-Pingel, S.Y. Ji, and D. Nunez et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure Circ Res 104 2009 403 411
53. A.P. Halestrap, S.J. Clarke, and S.A. Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection Cardiovasc Res 61 2004 372 385
54. A.P. Halestrap, and P. Pasdois The role of the mitochondrial permeability transition pore in heart disease Biochim Biophys Acta 1787 2009 1402 1415
55. P.J. Hanley, M. Mickel, M. Loffler, U. Brandt, and J. Daut K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart J Physiol 542 2002 735 741
56. D.G. Hardie, F.A. Ross, and S.A. Hawley AMP-activated protein kinase: a target for drugs both ancient and modern Chem Biol 19 2012 1222 1236
57. D.G. Hardie, F.A. Ross, and S.A. Hawley AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat Rev Mol Cell Biol 13 2012 251 262
58. D.J. Hausenloy, H.L. Maddock, G.F. Baxter, and D.M. Yellon Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55 2002 534 543
59. D.J. Hausenloy, S.B. Ong, and D.M. Yellon The mitochondrial permeability transition pore as a target for preconditioning and postconditioning Basic Res Cardiol 104 2009 189 202
60. D.J. Hausenloy, and D.M. Yellon New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460
61. D.J. Hausenloy, and D.M. Yellon Remote ischaemic preconditioning: underlying mechanisms and clinical application Cardiovasc Res 79 2008 377 386
62. F.R. Heinzel, Y. Luo, X. Li, K. Boengler, A. Buechert, and D. Garcia-Dorado et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice Circ Res 97 2005 583 586
63. S. Horman, C. Beauloye, J.L. Vanoverschelde, and L. Bertrand AMP-activated protein kinase in the control of cardiac metabolism and remodeling Curr Heart Fail Rep 9 2012 164 173
64. F. Ikeno, K. Inagaki, M. Rezaee, and D. Mochly-Rosen Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage Cardiovasc Res 73 2007 699 709
65. K. Inagaki, L. Chen, F. Ikeno, F.H. Lee, K. Imahashi, and D.M. Bouley et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo Circulation 108 2003 2304 2307
66. F. Kerendi, H. Kin, M.E. Halkos, R. Jiang, A.J. Zatta, and Z.Q. Zhao et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors Basic Res Cardiol 100 2005 404 412
67. A.S. Kim, E.J. Miller, T.M. Wright, J. Li, D. Qi, and K. Atsina et al. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury J Mol Cell Cardiol 51 2011 24 32
68. A. Kis, G.F. Baxter, and D.M. Yellon Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2 Cardiovasc Drugs Ther 17 2003 415 425
69. R.C. Kukreja Mechanism of reactive oxygen species generation after opening of mitochondrial KATP channels Am J Physiol Heart Circ Physiol 291 2006 H2041 H2043
70. K.T. Lamont, S. Somers, L. Lacerda, L.H. Opie, and S. Lecour Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection J Pineal Res 50 2011 374 380
71. C.L. Lawrence, B. Billups, G.C. Rodrigo, and N.B. Standen The KATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation Br J Pharmacol 134 2001 535 542
72. S. Lecour Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 47 2009 32 40
73. S. Lecour, R.M. Smith, B. Woodward, L.H. Opie, L. Rochette, and M.N. Sack Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection J Mol Cell Cardiol 34 2002 509 518
74. S. Lecour, N. Suleman, G.A. Deuchar, S. Somers, L. Lacerda, and B. Huisamen et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase) Circulation 112 2005 3911 3918
75. J. Li, D.L. Coven, E.J. Miller, X. Hu, M.E. Young, and D. Carling et al. Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart Am J Physiol Heart Circ Physiol 291 2006 H1927 H1934
76. S.L. Longnus, R.B. Wambolt, H.L. Parsons, R.W. Brownsey, and M.F. Allard 5-Aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms Am J Physiol Regul Integr Comp Physiol 284 2003 R936 R944
77. N. Mewton, P. Croisille, G. Gahide, G. Rioufol, E. Bonnefoy, and I. Sanchez et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction J Am Coll Cardiol 55 2010 1200 1205
78. T. Miura, and T. Miki Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy Basic Res Cardiol 103 2008 501 513
79. K. Mullane Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury Cardiovasc Res 27 1993 43 47
80. C.L. Murriel, E. Churchill, K. Inagaki, L.I. Szweda, and D. Mochly-Rosen Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria J Biol Chem 279 2004 47985 47991
81. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
82. N. Musi, and L.J. Goodyear Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes Curr Drug Targets Immune Endocr Metabol Disord 2 2002 119 127
83. + channels in cardiac muscle Nature 305 1983 147 148
84. + channels and their role in cardioprotection Circ Res 94 2004 420 432
85. B. O'Rourke Mitochondrial ion channels Annu Rev Physiol 69 2007 19 49
86. M.A. Paiva, Z. Rutter-Locher, L.M. Goncalves, L.A. Providencia, S.M. Davidson, and D.M. Yellon et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury Am J Physiol Heart Circ Physiol 300 2011 H2123 H2134
87. R.D. Patten, I. Pourati, M.J. Aronovitz, J. Baur, F. Celestin, and X. Chen et al. 17Beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling Circ Res 95 2004 692 699
88. C. Penna, D. Mancardi, R. Rastaldo, and P. Pagliaro Cardioprotection: a radical view Free radicals in pre and postconditioning Biochim Biophys Acta 1787 2009 781 793
89. C. Penna, M.G. Perrelli, and P. Pagliaro Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications Antioxid Redox Signal 18 2013 556 599
90. C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, and N. Mewton et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
91. M.N. Sack, and D.M. Yellon Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation J Am Coll Cardiol 41 2003 1404 1407
92. M.J. Sanders, Z.S. Ali, B.D. Hegarty, R. Heath, M.A. Snowden, and D. Carling Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family J Biol Chem 282 2007 32539 32548
93. N. Sasaki, T. Sato, A. Ohler, B. O'Rourke, and E. Marban Activation of mitochondrial ATP-dependent potassium channels by nitric oxide Circulation 101 2000 439 445
94. D. Schulman, D.S. Latchman, and D.M. Yellon Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway Am J Physiol Heart Circ Physiol 283 2002 H1481 H1488
95. L. Schwartz Longacre, R.A. Kloner, A.E. Arai, C.P. Baines, R. Bolli, and E. Braunwald et al. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute workshop Circulation 124 2011 1172 1179
96. P. Staat, G. Rioufol, C. Piot, Y. Cottin, T.T. Cung, and I. L'Huillier et al. Postconditioning the human heart Circulation 112 2005 2143 2148
97. H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, and G. Rioufol et al. Long-term benefit of postconditioning Circulation 117 2008 1037 1044
98. D. Weihrauch, J.G. Krolikowski, M. Bienengraeber, J.R. Kersten, D.C. Warltier, and P.S. Pagel Morphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits Anesth Analg 101 2005 942 949 (table of contents)
99. Z. Yao, and G.J. Gross Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs Circulation 89 1994 1769 1775
100. Z. Yao, T. Mizumura, D.A. Mei, and G.J. Gross KATP channels and memory of ischemic preconditioning in dogs: synergism between adenosine and KATP channels Am J Physiol 272 1997 H334 H342
101. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
102. Z.Q. Zhao, J.S. Corvera, M.E. Halkos, F. Kerendi, N.P. Wang, and R.A. Guyton et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
103. D.B. Zorov, C.R. Filburn, L.O. Klotz, J.L. Zweier, and S.J. Sollott Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes J Exp Med 192 2000 1001 1014
104. D.B. Zorov, M. Juhaszova, and S.J. Sollott Mitochondrial ROS-induced ROS release: an update and review Biochim Biophys Acta 1757 2006 509 517